<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Psychol</journal-id><journal-id journal-id-type="iso-abbrev">Front Psychol</journal-id><journal-id journal-id-type="publisher-id">Front. Psychol.</journal-id><journal-title-group><journal-title>Frontiers in Psychology</journal-title></journal-title-group><issn pub-type="epub">1664-1078</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29375445</article-id><article-id pub-id-type="pmc">5768622</article-id><article-id pub-id-type="doi">10.3389/fpsyg.2017.02333</article-id><article-categories><subj-group subj-group-type="heading"><subject>Psychology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>EMDR as Add-On Treatment for Psychiatric and Traumatic Symptoms in Patients with Substance Use Disorder</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Carletto</surname><given-names>Sara</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><xref ref-type="author-notes" rid="fn003"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/304346/overview"/></contrib><contrib contrib-type="author"><name><surname>Oliva</surname><given-names>Francesco</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn003"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/319703/overview"/></contrib><contrib contrib-type="author"><name><surname>Barnato</surname><given-names>Micaela</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/453475/overview"/></contrib><contrib contrib-type="author"><name><surname>Antonelli</surname><given-names>Teresa</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/453435/overview"/></contrib><contrib contrib-type="author"><name><surname>Cardia</surname><given-names>Antonina</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/436560/overview"/></contrib><contrib contrib-type="author"><name><surname>Mazzaferro</surname><given-names>Paolo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Raho</surname><given-names>Carolina</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/436700/overview"/></contrib><contrib contrib-type="author"><name><surname>Ostacoli</surname><given-names>Luca</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/304639/overview"/></contrib><contrib contrib-type="author"><name><surname>Fernandez</surname><given-names>Isabel</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/284783/overview"/></contrib><contrib contrib-type="author"><name><surname>Pagani</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/155247/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Clinical and Biological Sciences Department, University of Turin</institution>, <addr-line>Orbassano</addr-line>, <country>Italy</country></aff><aff id="aff2"><sup>2</sup><institution>EMDR Italy Association</institution>, <addr-line>Bovisio Masciago</addr-line>, <country>Italy</country></aff><aff id="aff3"><sup>3</sup><institution>Associazione l'Arcobaleno, Comunit&#x000e0; di Capodarco di Fermo</institution>, <addr-line>Fermo</addr-line>, <country>Italy</country></aff><aff id="aff4"><sup>4</sup><institution>Ser.T</institution>, <addr-line>Limbiate</addr-line>, <country>Italy</country></aff><aff id="aff5"><sup>5</sup><institution>Clinical and Oncological Psychology, Citt&#x000e0; della Salute e della Scienza Hospital of Turin</institution>, <addr-line>Turin</addr-line>, <country>Italy</country></aff><aff id="aff6"><sup>6</sup><institution>Institute of Cognitive Sciences and Technologies, National Research Council (CNR)</institution>, <addr-line>Rome</addr-line>, <country>Italy</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Lorys Castelli, Universit&#x000e0; degli Studi di Torino, Italy</p></fn><fn fn-type="edited-by"><p>Reviewed by: Xiao Zhou, Tel Aviv University, Israel; Rossella Guerini, Universit&#x000e0; degli Studi Roma Tre, Italy</p></fn><corresp id="fn001">*Correspondence: Sara Carletto <email xlink:type="simple">sara.carletto@unito.it</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Clinical and Health Psychology, a section of the journal Frontiers in Psychology</p></fn><fn fn-type="other" id="fn003"><p>&#x02020;These authors have contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>11</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>8</volume><elocation-id>2333</elocation-id><history><date date-type="received"><day>15</day><month>7</month><year>2017</year></date><date date-type="accepted"><day>21</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Carletto, Oliva, Barnato, Antonelli, Cardia, Mazzaferro, Raho, Ostacoli, Fernandez and Pagani.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Carletto, Oliva, Barnato, Antonelli, Cardia, Mazzaferro, Raho, Ostacoli, Fernandez and Pagani</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><bold>Background:</bold> Substance use disorders (SUD) are patterns of substance use leading to severe impairment on social, working and economic levels. <italic>In vivo</italic> and clinical findings have enhanced the role of the brain's stress-related system in maintaining SUD behaviors. Several studies have also revealed a high prevalence of post-traumatic symptoms among SUD patients, suggesting that a trauma-informed treatment approach could lead to better treatment outcomes. However, only few studies have evaluated the use of eye movement desensitization and reprocessing (EMDR) in SUD without consistent results. The aim of the present pilot study was to assess the efficacy of a combined trauma-focused (TF) and addiction-focused (AF) EMDR intervention in treating post-traumatic and stress-related symptoms of patients with SUD.</p><p><bold>Methods:</bold> Forty patients with different SUD were enrolled in the study. Twenty patients underwent treatment as usual (TAU), the other 20 patients were treated with TAU plus 24 weekly sessions of EMDR. All patients were assessed before and after intervention for several psychological dimensions using specific tools (i.e., BDI-II, DES, IES-R, STAI, and SCL-90-GSI). A repeated measure MANOVA was performed to evaluate both between groups (TAU + EMDR vs. TAU) and within group (pre- vs. post-intervention) effects and interactions. A secondary outcome was the dichotomous variable yielded by the urine drug testing immunoassay (yes/no).</p><p><bold>Results:</bold> The RM-MANOVA revealed both a significant pre&#x02013;post main effect (<italic>p</italic> &#x0003c; 0.001), and a significant group-by-time main effect (<italic>p</italic> &#x0003c; 0.001). Significant improvements on IES-R, DES, and SCL-90-GSI scales were shown in both groups according to time effects (<italic>p</italic> &#x0003c; 0.05). However, significant greater effects were found for TAU + EMDR group than TAU group. No differences were found between TAU and TAU + EMDR groups in terms of urine drug immunoassay results before and after the interventions.</p><p><bold>Conclusions:</bold> The TAU + EMDR group showed a significant improvement of post-traumatic and dissociative symptoms, accompanied by a reduction in anxiety and overall psychopathology levels, whereas TAU group showed a significant reduction only in post-traumatic symptoms. Although our results can only be considered preliminary, this study suggests that a combined TF- and AF- EMDR protocol is an effective and well-accepted add-on treatment for patients with SUD.</p></abstract><kwd-group><kwd>eye movement desensitization and reprocessing</kwd><kwd>substance use disorder</kwd><kwd>traumatic stress</kwd><kwd>dissociation</kwd><kwd>anxiety</kwd><kwd>depression</kwd><kwd>psychiatric symptoms</kwd><kwd>adverse childhood experiences</kwd></kwd-group><counts><fig-count count="0"/><table-count count="3"/><equation-count count="0"/><ref-count count="58"/><page-count count="8"/><word-count count="6876"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Substance use disorders (SUD) are pathological patterns of behaviors related to substance use leading to severe impairment of familial, social and working relationships as well as of economic conditions (American Psychiatric Association, <xref rid="B2" ref-type="bibr">2013</xref>).</p><p>Although the neurobiological circuitry that is associated with drug reward has been broadened in recent years, the meso-cortical-striatal dopamine system is still the most important pathway involved in the rewarding properties of almost all drugs (Koob and Volkow, <xref rid="B29" ref-type="bibr">2016</xref>).</p><p>However, <italic>in vivo</italic> and clinical findings have also enhanced the role of brain's stress-related system in maintaining SUD behaviors: the chronic administration of all major drugs with dependence or abuse potential is associated with corticotropin-releasing factor variation leading to both hypothalamic-pituitary-adrenal axis and brain stress system dysregulation (Koob, <xref rid="B28" ref-type="bibr">2013</xref>).</p><p>The increase of corticotropin-releasing factor, dynorphin, and norepinephrine recruited in the extended amygdala contributes to the development of negative emotional states during acute withdrawal (such as chronic irritability, dysphoria, and loss of motivation; Koob and Volkow, <xref rid="B29" ref-type="bibr">2016</xref>).</p><p>From an epidemiologic point of view, patients having any lifetime SUD showed higher risk of also having a post-traumatic stress disorder (PTSD; OR = 1.6, 95% CI = 1.27&#x02013;2.10, Grant et al., <xref rid="B22" ref-type="bibr">2016</xref>) with a prevalence of current PTSD ranging from 15 to 42% (Mills et al., <xref rid="B35" ref-type="bibr">2005</xref>; Reynolds et al., <xref rid="B47" ref-type="bibr">2005</xref>, <xref rid="B46" ref-type="bibr">2011</xref>; Driessen et al., <xref rid="B17" ref-type="bibr">2008</xref>).</p><p>Moreover, some studies conducted on SUD showed that 67&#x02013;92% of the patients report having experienced at least one traumatic event according to the DSM-IV PTSD criterion A (Dragan and Lis-Turlejska, <xref rid="B16" ref-type="bibr">2007</xref>; Reynolds et al., <xref rid="B46" ref-type="bibr">2011</xref>).</p><p>Furthermore, several studies have also reported a strong relationship between exposure to severe stress in childhood and substance abuse (Dube et al., <xref rid="B18" ref-type="bibr">2003</xref>; Green et al., <xref rid="B23" ref-type="bibr">2010</xref>). One of the most important studies, conducted by the Center for Disease Control along with the Kaiser Hospital in San Diego, released the landmark Adverse Childhood Experience (ACE) study, showing that individuals who experienced four or more types of ACEs were at a four to 12-fold increased risk of developing alcohol or drug abuse problems (Felitti et al., <xref rid="B20" ref-type="bibr">1998</xref>).</p><p>Research has shown that substance abuse treatment using a trauma-informed approach could lead to better treatment outcomes, such as greater symptom reduction and increased retention in treatment (Amaro et al., <xref rid="B1" ref-type="bibr">2007</xref>; LeTendre and Reed, <xref rid="B31" ref-type="bibr">2017</xref>).</p><p>Such involvement of stress systems, trauma, and PTSD in SUD suggested a possible role of intervention possibly impacting on traumatic and stress disorders in the treatment of patients with SUD.</p><p>Among the different psychological approaches, eye movement desensitization and reprocessing (EMDR) has emerged as an evidence-based therapy for the treatment of psychological sequelae of traumatic events and other negative stressful experiences (Shapiro, <xref rid="B50" ref-type="bibr">2014</xref>).</p><p>EMDR is a psychotherapeutic approach that focuses on trauma elaboration. It is guided by the adaptive information processing (AIP) model, that posits that stressful events not fully processed and integrated into the already existing memory networks are stored in a dysfunctional way. A distinct characteristic of EMDR therapy is the use of alternating bilateral stimulation (eye movements, tactile, or audio), which appears to produce a physiological effect promoting accelerated reprocessing of dysfunctionally stored information related to the traumatic event (Jeffries and Davis, <xref rid="B26" ref-type="bibr">2013</xref>; Carletto et al., <xref rid="B9" ref-type="bibr">2017</xref>; Pagani et al., <xref rid="B39" ref-type="bibr">2017</xref>).</p><p>EMDR is considered one of the elective psychotherapeutic treatments for PTSD, according to several meta-analyses and clinical guidelines (Van Etten and Taylor, <xref rid="B54" ref-type="bibr">1998</xref>; Davidson and Parker, <xref rid="B13" ref-type="bibr">2001</xref>; Bradley et al., <xref rid="B7" ref-type="bibr">2005</xref>; National Collaborating Centre for Mental Health, <xref rid="B38" ref-type="bibr">2005</xref>; Bisson et al., <xref rid="B5" ref-type="bibr">2013</xref>; WHO, <xref rid="B58" ref-type="bibr">2013</xref>; Chen et al., <xref rid="B11" ref-type="bibr">2014</xref>, <xref rid="B10" ref-type="bibr">2015</xref>) and its neurobiological effects are also supported by neuroimaging findings (Pagani et al., <xref rid="B41" ref-type="bibr">2012</xref>, <xref rid="B40" ref-type="bibr">2015</xref>; Boukezzi et al., <xref rid="B6" ref-type="bibr">2017</xref>).</p><p>Furthermore, in recent years the use of EMDR has expanded beyond PTSD and several studies have reported its efficacy for treatment of trauma-associated symptoms in patients with other psychiatric conditions (for a review see Valiente-G&#x000f3;mez et al., <xref rid="B52" ref-type="bibr">2017</xref>). Among these, several protocols of treatment were developed in order to address traumatic experiences of SUD patients.</p><p>The clinical application of trauma-focused EMDR (TF-EMDR) in some studies resulted in EMDR being efficacious in the treatment of traumatic symptoms, but not in addiction behavior severity (see reviews by Roberts et al., <xref rid="B48" ref-type="bibr">2015</xref> and Markus and Hornsveld, <xref rid="B33" ref-type="bibr">2017</xref>). Subsequently, some authors focused on the role of TF-EMDR in patients with SUD without PTSD, considering different types of outcomes even in relation to the addiction with fairly positive results but without conclusive findings.</p><p>Finally, as a third possible application of EMDR in SUD, there were some proposals of addiction-focused EMDR (AF-EMDR) protocols, such as the desensitization of triggers and urge reprocessing (DeTUR) protocol by Popky (<xref rid="B43" ref-type="bibr">2005</xref>), the feeling-state addiction protocol (FSAP) by Miller (<xref rid="B34" ref-type="bibr">2010</xref>) and the craving extinguished (CravEx) protocol by Hase et al. (<xref rid="B25" ref-type="bibr">2008</xref>). All these protocols were specifically focused on the addiction rather on trauma but only the CravEx was clinically evaluated in a randomized clinical trial. Comparing treatment as usual (TAU) with CravEx plus TAU in a sample of patients with alcohol use disorder, Hase et al. (<xref rid="B25" ref-type="bibr">2008</xref>) have found a significant reduction in craving and depression severity up to 1 month after treatment.</p><p>To the best of our knowledge, no studies have yet evaluated the efficacy of both trauma and addiction-focused protocols on the relapse rate and stress-related symptoms of patients with SUD. Therefore, the aim of the present pilot study was to assess the efficacy of a combined trauma-focused and addiction-focused EMDR protocol in treating post-traumatic and stress-related symptoms of patients with SUD. We hypothesized that this combined adjunctive EMDR intervention would be more effective than a TAU intervention.</p></sec><sec sec-type="materials and methods" id="s2"><title>Materials and methods</title><sec><title>Design</title><p>This was a quasi-experimental study investigating the efficacy of an additional EMDR treatment as compared with TAU alone in patients diagnosed with SUD.</p></sec><sec><title>Setting</title><p>The participants were recruited in two settings: an outpatient territorial service for drug addiction in northern Italy (Ser.T. of Limbiate, MI) and a residential facility in central Italy (Comunit&#x000e0; di Capodarco di Fermo, FM) from March 2015 to May 2016.</p><p>The study was approved by the Medical Ethics Committee of Azienda Territoriale dei Servizi of Brianza (MB, Italy) and by the Board of Directors of Capodarco (FM, Italy). Informed written consent was obtained from all the participants.</p></sec><sec><title>Participants</title><p>The subjects of the study were patients with a diagnosis of SUD, who were referred to one of the two above-mentioned centers for drug addiction treatment.</p><p>Inclusion criteria were as follows: (1) a diagnosis of SUD, according to DSM-5; (2) age between 18 and 65 years; (3) fluent Italian language; (4) legal capacity to consent to the treatment; (5) maintenance of psychotropic medications throughout the study.</p><p>Exclusion criteria were as follows: (1) having a pathological gambling disorder without comorbidity with other SUDs; (2) presence of other severe psychiatric disorders such as psychosis or bipolar disorder; (3) cognitive disorders such as overt dementia; (4) suicide attempts; (5) current pregnancy.</p></sec><sec><title>Assessment</title><p>The recruitment of participants was carried out by a psychiatrist and psychologist who proposed participation in the research protocol to patients during a clinical visit in the outpatient setting and during the first visit after admission in the inpatient setting. The research protocol was proposed to consecutive patients who met the inclusion criteria, with an explanation of the aims of the study, and patients were asked whether they were willing to receive an additional psychotherapeutic intervention (EMDR) other than TAU. Patients could choose the group to which they wanted to be assigned (TAU or TAU + EMDR). On reaching the maximum number of patients in the TAU + EMDR group, the remaining patients were assigned to the TAU alone group.</p><p>The psychological assessment was performed by psychologists independent of the research protocol, using the same timing and tools, i.e., at baseline before the first session of treatment (T0), and after the end of treatment (T1).</p><p>The following psychological self-report questionnaires were administered:</p><p><italic>Impact of Event Scale&#x02014;Revised (IES-R)</italic>. The IES-R (Weiss and Marmar, <xref rid="B57" ref-type="bibr">1997</xref>) is a 22- item self-report questionnaire consisting of three subscales (eight items relate to intrusions, eight items evaluate avoidance, and six items assess hyperarousal). The scale assesses subjective distress caused by traumatic events. An IES-R score equal to or &#x0003e;33 represents the best cut-off for a probable diagnosis of PTSD. The IES-R was found to be highly internally consistent (Cronbach's alpha, &#x003b1; = 0.96; Creamer et al., <xref rid="B12" ref-type="bibr">2003</xref>).</p><p><italic>State-Trait Anxiety Inventory (STAI-Y)</italic>. The STAI-Y (Spielberger et al., <xref rid="B51" ref-type="bibr">1983</xref>) is used to measure the presence and severity of current symptoms of anxiety (state anxiety; STAI-1) and a generalized propensity to be anxious (trait anxiety; STAI-2). Range of scores for each subtest is 20&#x02013;80, the higher score indicating greater anxiety. A cutoff point of 39&#x02013;40 has been suggested to detect clinically significant symptoms for the state anxiety scale. The STAI-Y has shown an adequate to excellent internal reliability (&#x003b1; = 0.86&#x02013;0.95).</p><p><italic>Beck Depression Inventory-II (BDI-II)</italic>. The BDI-II (Beck and Steer, <xref rid="B3" ref-type="bibr">1993</xref>) is a 21-item self-report instrument that assesses the presence and severity of depression symptoms. A score above 13 indicates presence of depression symptoms. The internal consistency of the BDI-II is good to excellent (&#x003b1; = 0.83&#x02013;0.96; Wang and Gorenstein, <xref rid="B56" ref-type="bibr">2013</xref>).</p><p><italic>Symptom Checklist 90 Items revised version (SCL-90- R)</italic> (Derogatis et al., <xref rid="B15" ref-type="bibr">1973</xref>; Derogatis, <xref rid="B14" ref-type="bibr">1994</xref>) is a 90-items self-report questionnaire that evaluates a broad range of psychological problems and symptoms of psychopathology. For the purpose of this study we chose to utilize the Global Severity Index (GSI), as it represents the best global indicator of the intensity of psychic distress reported by the subject and it demonstrated a high Cronbach's alpha value (&#x003b1; = 0.97; Prinz et al., <xref rid="B45" ref-type="bibr">2013</xref>). This global index combines information about the number of reported symptoms and the intensity of perceived discomfort. A score between 55 and 65 indicates a distress level of moderate intensity, while a score above 65 reveals a severe intensity of discomfort, beyond the threshold of clinical attention.</p><p><italic>Dissociative Experiences Scale (DES)</italic> (Bernstein and Putnam, <xref rid="B4" ref-type="bibr">1986</xref>; Frischholz et al., <xref rid="B21" ref-type="bibr">1990</xref>) is a brief, 28-item, self-report inventory of the frequency of dissociative experiences. It represents a reliable and valid measure for determining the contribution of dissociation to various psychiatric disorders and a screening instrument for dissociative disorders. High levels of dissociation are indicated by scores of 30 or more. The DES has an excellent internal consistency, with Cronbach's alpha ranging from 0.96 to 0.97 (Dubester and Braun, <xref rid="B19" ref-type="bibr">1995</xref>).</p><p>The <italic>Adverse Childhood Experience Questionnaire (ACE)</italic> (Felitti et al., <xref rid="B20" ref-type="bibr">1998</xref>) is a 10-item self-report measure developed for the ACE study to identify childhood experiences of abuse and neglect. The internal consistency of the ACE questionnaire is adequate (&#x003b1; = 0.88; Murphy et al., <xref rid="B36" ref-type="bibr">2014</xref>). This questionnaire was administered only at baseline.</p></sec><sec><title>Treatments</title><sec><title>Treatment as usual</title><p>All patients received TAU, which consisted of standard treatment for recovery from SUD in the National Health Service in Italy. TAU included clinical interviews with the addiction specialist and administration of medications appropriate for each patient (e.g., alcohol craving, heroin substitute treatment). Comorbid psychiatric conditions such as depression or anxiety disorders were treated in accordance with the patient's needs, including appropriate medication.</p><p>Lastly, TAU included psychological treatment (both individual and group sessions) and participation in psycho-educational group sessions.</p></sec><sec><title>Eye movement desensitization and reprocessing</title><p>Participants received 24 weekly EMDR sessions over a period of 6 months. The EMDR treatment used in this study incorporated both elements of the classic TF-EMDR protocol (Shapiro, <xref rid="B49" ref-type="bibr">2001</xref>) and of the existing AF-EMDR protocols (Hase, <xref rid="B24" ref-type="bibr">2010</xref>; Knipe, <xref rid="B27" ref-type="bibr">2010</xref>; Miller, <xref rid="B34" ref-type="bibr">2010</xref>; Popky, <xref rid="B44" ref-type="bibr">2010</xref>), in accordance with the Palette of EMDR Interventions in Addiction (PEIA; Markus and Hornsveld, <xref rid="B33" ref-type="bibr">2017</xref>).</p><p>The EMDR treatment steps were as follows:</p><list list-type="order"><list-item><p>Building a positive therapeutic relationship;</p></list-item><list-item><p>Information gathering (trauma history, addiction history);</p></list-item><list-item><p>Strengthening the motivation for treatment through positive and achievable therapeutic goals and enhancing personal resources;</p></list-item><list-item><p>Desensitization of traumatic events in chronological order;</p></list-item><list-item><p>Desensitization of the &#x0201c;first time&#x0201d; memory and the dependence of precipitating factors;</p></list-item><list-item><p>Desensitization of the level of urge;</p></list-item><list-item><p>Desensitization of the recall of the relapse;</p></list-item><list-item><p>Desensitizing triggers of triggering behavior;</p></list-item><list-item><p>Installing a positive state for each triggering factor.</p></list-item></list><p>EMDR treatment was provided by four clinical psychotherapists specialized in EMDR therapy (who at least had completed the Level II EMDR program). The EMDR therapists were supervised monthly by an EMDR consultant.</p></sec></sec><sec><title>Statistical analyses</title><p>Data were processed and analyzed using the Statistical Package for Social Sciences (SPSS version 22.0; Chicago, IL, USA).</p><p>Both parametric and nonparametric tests were used, in accordance with Shapiro&#x02013;Wilk as a test for normality. Baseline group differences were assessed using Student's <italic>t</italic>-test or Mann&#x02013;Whitney <italic>U</italic>-test to compare the two groups for continuous measures and Fisher's Exact Test for categorical measures.</p><p>GLM repeated measures multivariate ANOVA (RM-MANOVA) was used to analyze the main pre- and post- intervention effects and interactions both between and within TAU + EMDR and TAU groups. Pairwise comparison between groups were made by simple contrast and are reported as means difference with the Sidak correction 95% confidence interval (95%CI) for multiple comparisons.</p><p>A <italic>p</italic> &#x0003c; 0.05 was considered statistically significant throughout all of the analyses.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><p>A total of 40 patients were enrolled in the study: 20 were assigned to the TAU + EMDR intervention and the other 20 patients were assigned to the TAU treatment. We did not register any dropout from the treatments.</p><p>Table <xref ref-type="table" rid="T1">1</xref> presents the sociodemographic characteristics of these patients at baseline. There were no significant differences in demographics between the two groups at baseline (T0), except for adverse childhood experiences, which were more frequent in the TAU + EMDR group (Table <xref ref-type="table" rid="T1">1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic data of participants at baseline.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>EMDR (<italic>N</italic> = 20) Mean (<italic>SD</italic>)/Median (IQR)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>TAU (<italic>N</italic> = 20) Mean (<italic>SD</italic>)/Median (IQR)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>p</italic></bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (years)</td><td valign="top" align="center" rowspan="1" colspan="1">32 (8)</td><td valign="top" align="center" rowspan="1" colspan="1">32 (19)</td><td valign="top" align="center" rowspan="1" colspan="1">0.820<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Years of substance use</td><td valign="top" align="center" rowspan="1" colspan="1">19.40 (7.98)</td><td valign="top" align="center" rowspan="1" colspan="1">21.10 (9.59)</td><td valign="top" align="center" rowspan="1" colspan="1">0.546<xref ref-type="table-fn" rid="TN2"><sup>b</sup></xref></td></tr><tr style="border-bottom: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">Adverse Childhood Experiences</td><td valign="top" align="center" rowspan="1" colspan="1">4 (5)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2)</td><td valign="top" align="center" rowspan="1" colspan="1">0.004<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></td></tr><tr style="border-bottom: thin solid #000000;"><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"><italic><bold>n</bold></italic>
<bold>(%)</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><italic><bold>n</bold></italic>
<bold>(%)</bold></td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Gender</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.487<xref ref-type="table-fn" rid="TN3"><sup>c</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;Female</td><td valign="top" align="center" rowspan="1" colspan="1">2 (10)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;Male</td><td valign="top" align="center" rowspan="1" colspan="1">18 (90)</td><td valign="top" align="center" rowspan="1" colspan="1">20 (100)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Marital status</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.410<xref ref-type="table-fn" rid="TN3"><sup>c</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;Single</td><td valign="top" align="center" rowspan="1" colspan="1">17 (85)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (70)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;Married</td><td valign="top" align="center" rowspan="1" colspan="1">1 (5)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (20)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;Separated/divorced</td><td valign="top" align="center" rowspan="1" colspan="1">2 (10)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (10)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Level of education</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.198<xref ref-type="table-fn" rid="TN3"><sup>c</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;Primary school</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (15)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;Low secondary school</td><td valign="top" align="center" rowspan="1" colspan="1">9 (45)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (50)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;High secondary school</td><td valign="top" align="center" rowspan="1" colspan="1">11 (55)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (35)</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p><italic>EMDR, Eye Movement Desensitization and Reprocessing group; TAU, Therapy As Usual group</italic>.</p><fn id="TN1"><label>a</label><p><italic>Mann&#x02013;Whitney U-test</italic>.</p></fn><fn id="TN2"><label>b</label><p><italic>Pearson's independent samples t-test</italic>.</p></fn><fn id="TN3"><label>c</label><p><italic>Fisher's exact test</italic>.</p></fn></table-wrap-foot></table-wrap><p>There were several differences between the two groups at baseline. Overall, patients in the TAU + EMDR group showed higher post-traumatic stress and anxiety symptoms and more psychiatric symptoms.</p><p>We evaluated whether the different psychotherapy treatments (TAU + EMDR or TAU) administered to the patients had a different impact on the psychological variables of interests. A repeated-measures MANOVA was performed on the pre- and post-intervention clinical scores (IES-R, DES, SCL-90-GSI, STAI-1, STAI-2, BDI-II), comparing group and time effects and interactions between group and time.</p><p>The RM-MANOVA yielded a significant pre&#x02013;post main effect [<italic>F</italic><sub>(6, 33)</sub> = 10.102, <italic>p</italic> &#x0003c; 0.001; &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.647], and a significant interaction between the pre&#x02013;post measures and the treatment condition [<italic>F</italic><sub>(6, 33)</sub> = 7.830, <italic>p</italic> &#x0003c; 0.001; &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.587].</p><p>Significant time effects were found across both groups for all variables except for STAI-1 and STAI-2, indicating that the mean participant scores improved from time 0 (pre-intervention) to time 1 (post-intervention) on all variables except for anxiety symptoms (Table <xref ref-type="table" rid="T2">2</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Comparison of clinical variables for the two groups (TAU and TAU + EMDR).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;" rowspan="1"><bold>Pre-treatment</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>p</italic></bold></th><th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;" rowspan="1"><bold>Post-treatment</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>p</italic></bold></th><th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;" rowspan="1"><bold>Effect Time</bold></th><th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;" rowspan="1"><bold>Effect Time &#x000d7; Group</bold></th></tr><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>TAU (<italic>N</italic> = 20)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>TAU + EMDR (<italic>N</italic> = 20)</bold></th><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>TAU (<italic>N</italic> = 20)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>TAU + EMDR (<italic>N</italic> = 20)</bold></th><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>F</italic></bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>P</italic></bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>&#x003b7;<sup>2</sup><italic><sub><italic>p</italic></sub></italic></bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>F</italic></bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>P</italic></bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>&#x003b7;<sup>2</sup><italic><sub><italic>p</italic></sub></italic></bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">BDI-II</td><td valign="top" align="center" rowspan="1" colspan="1">11.60 (7.45)</td><td valign="top" align="center" rowspan="1" colspan="1">18.35 (14.08)</td><td valign="top" align="center" rowspan="1" colspan="1">0.066</td><td valign="top" align="center" rowspan="1" colspan="1">10.10 (7.58)</td><td valign="top" align="center" rowspan="1" colspan="1">11.65 (12.54)</td><td valign="top" align="center" rowspan="1" colspan="1">0.639</td><td valign="top" align="center" rowspan="1" colspan="1">8.646</td><td valign="top" align="center" rowspan="1" colspan="1">0.006</td><td valign="top" align="center" rowspan="1" colspan="1">0.185</td><td valign="top" align="center" rowspan="1" colspan="1">3.477</td><td valign="top" align="center" rowspan="1" colspan="1">0.070</td><td valign="top" align="center" rowspan="1" colspan="1">0.084</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">STAI-1</td><td valign="top" align="center" rowspan="1" colspan="1">41.95 (4.17)</td><td valign="top" align="center" rowspan="1" colspan="1">46.35 (5.26)</td><td valign="top" align="center" rowspan="1" colspan="1">0.006</td><td valign="top" align="center" rowspan="1" colspan="1">46.25 (5.28)</td><td valign="top" align="center" rowspan="1" colspan="1">43.50 (5.31)</td><td valign="top" align="center" rowspan="1" colspan="1">0.109</td><td valign="top" align="center" rowspan="1" colspan="1">0.459</td><td valign="top" align="center" rowspan="1" colspan="1">0.502</td><td valign="top" align="center" rowspan="1" colspan="1">0.012</td><td valign="top" align="center" rowspan="1" colspan="1">11.160</td><td valign="top" align="center" rowspan="1" colspan="1">0.002</td><td valign="top" align="center" rowspan="1" colspan="1">0.227</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">STAI-2</td><td valign="top" align="center" rowspan="1" colspan="1">42.05 (2.69)</td><td valign="top" align="center" rowspan="1" colspan="1">45.65 (5.49)</td><td valign="top" align="center" rowspan="1" colspan="1">0.012</td><td valign="top" align="center" rowspan="1" colspan="1">43.20 (3.14)</td><td valign="top" align="center" rowspan="1" colspan="1">42.60 (7.61)</td><td valign="top" align="center" rowspan="1" colspan="1">0.746</td><td valign="top" align="center" rowspan="1" colspan="1">1.476</td><td valign="top" align="center" rowspan="1" colspan="1">0.232</td><td valign="top" align="center" rowspan="1" colspan="1">0.037</td><td valign="top" align="center" rowspan="1" colspan="1">7.212</td><td valign="top" align="center" rowspan="1" colspan="1">0.011</td><td valign="top" align="center" rowspan="1" colspan="1">0.160</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">DES</td><td valign="top" align="center" rowspan="1" colspan="1">10.93 (8.07)</td><td valign="top" align="center" rowspan="1" colspan="1">15.69 (14.05)</td><td valign="top" align="center" rowspan="1" colspan="1">0.196</td><td valign="top" align="center" rowspan="1" colspan="1">8.53 (6.67)</td><td valign="top" align="center" rowspan="1" colspan="1">6.72 (7.13)</td><td valign="top" align="center" rowspan="1" colspan="1">0.411</td><td valign="top" align="center" rowspan="1" colspan="1">15.766</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">0.293</td><td valign="top" align="center" rowspan="1" colspan="1">5.279</td><td valign="top" align="center" rowspan="1" colspan="1">0.027</td><td valign="top" align="center" rowspan="1" colspan="1">0.122</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IES-R</td><td valign="top" align="center" rowspan="1" colspan="1">23.90 (15.35)</td><td valign="top" align="center" rowspan="1" colspan="1">39.65 (23.12)</td><td valign="top" align="center" rowspan="1" colspan="1">0.015</td><td valign="top" align="center" rowspan="1" colspan="1">12.30 (11.76)</td><td valign="top" align="center" rowspan="1" colspan="1">6.05 (5.88)</td><td valign="top" align="center" rowspan="1" colspan="1">0.040</td><td valign="top" align="center" rowspan="1" colspan="1">48.282</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">0.560</td><td valign="top" align="center" rowspan="1" colspan="1">11.438</td><td valign="top" align="center" rowspan="1" colspan="1">0.002</td><td valign="top" align="center" rowspan="1" colspan="1">0.231</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SCL-90-GSI</td><td valign="top" align="center" rowspan="1" colspan="1">62.65 (10.39)</td><td valign="top" align="center" rowspan="1" colspan="1">73.90 (2.94)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">61.95 (11.55)</td><td valign="top" align="center" rowspan="1" colspan="1">63.25 (12.37)</td><td valign="top" align="center" rowspan="1" colspan="1">0.733</td><td valign="top" align="center" rowspan="1" colspan="1">14.378</td><td valign="top" align="center" rowspan="1" colspan="1">0.001</td><td valign="top" align="center" rowspan="1" colspan="1">0.275</td><td valign="top" align="center" rowspan="1" colspan="1">11.050</td><td valign="top" align="center" rowspan="1" colspan="1">0.002</td><td valign="top" align="center" rowspan="1" colspan="1">0.225</td></tr></tbody></table><table-wrap-foot><p><italic>Data are mean (SD)</italic>.</p><p>TAU, Therapy As Usual group;</p><p><italic>TAU + EMDR, Eye Movement Desensitization and Reprocessing in addition to TAU group</italic>.</p></table-wrap-foot></table-wrap><p>Group-by-time interaction effects were found for IES-R, DES, SCL-90-GSI, STAI-1, and STAI-2 total scores, indicating that clinical improvements regarding these variables were different in the two treatment groups. No group-by-time interaction was found for BDI-II, showing that change on this measure was similar for both treatment groups (Table <xref ref-type="table" rid="T2">2</xref>).</p><p>Planned <italic>post-hoc</italic> analyses of simple effects of pre&#x02013;post were conducted for all variables with a significant group-by-time effect (DES, IES-R, SCL-90-GSI, STAI-1, STAI-2,) by GLM pairwise comparisons using the Sidak adjustment for multiple comparisons.</p><p>The two groups significantly differ for IES-R scores at baseline, with participants in the TAU + EMDR group showing higher post-traumatic symptoms than those in the TAU group (Table <xref ref-type="table" rid="T2">2</xref>). The analysis of simple effects over time indicated both groups had an improvement in post-traumatic symptoms (Table <xref ref-type="table" rid="T3">3</xref>), but the TAU + EMDR group scored significantly lower compared to the TAU group at post-treatment (Table <xref ref-type="table" rid="T2">2</xref>).</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Comparison between T0 and T1 of clinical variables for the two groups (TAU and TAU + EMDR).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" colspan="4" style="border-bottom: thin solid #000000;" rowspan="1"><bold>TAU</bold></th><th valign="top" align="center" colspan="4" style="border-bottom: thin solid #000000;" rowspan="1"><bold>TAU + EMDR</bold></th></tr><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>T0</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>T1</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Mean difference (95%CI)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>p</italic></bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>T0</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>T1</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Mean difference (95%CI)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>p</italic></bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">BDI-II</td><td valign="top" align="center" rowspan="1" colspan="1">11.60 (7.45)</td><td valign="top" align="center" rowspan="1" colspan="1">10.10 (7.58)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.500 (&#x02212;5.492; 2.492)</td><td valign="top" align="center" rowspan="1" colspan="1">0.452</td><td valign="top" align="center" rowspan="1" colspan="1">18.35 (14.08)</td><td valign="top" align="center" rowspan="1" colspan="1">11.65 (12.54)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;6.700 (&#x02212;10.692; &#x02212;2.708)</td><td valign="top" align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1">STAI-1</td><td valign="top" align="center" rowspan="1" colspan="1">41.95 (4.17)</td><td valign="top" align="center" rowspan="1" colspan="1">46.25 (5.28)</td><td valign="top" align="center" rowspan="1" colspan="1">4.300 (1.236; 7.384)</td><td valign="top" align="center" rowspan="1" colspan="1">0.007</td><td valign="top" align="center" rowspan="1" colspan="1">46.35 (5.26)</td><td valign="top" align="center" rowspan="1" colspan="1">43.50 (5.31)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.850 (&#x02212;5.914; 0.214)</td><td valign="top" align="center" rowspan="1" colspan="1">0.067</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">STAI-2</td><td valign="top" align="center" rowspan="1" colspan="1">42.05 (2.69)</td><td valign="top" align="center" rowspan="1" colspan="1">43.20 (3.14)</td><td valign="top" align="center" rowspan="1" colspan="1">1.150 (&#x02212;1.089; 3.389)</td><td valign="top" align="center" rowspan="1" colspan="1">0.305</td><td valign="top" align="center" rowspan="1" colspan="1">45.65 (5.49)</td><td valign="top" align="center" rowspan="1" colspan="1">42.60 (7.61)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;3.050 (&#x02212;5.289; &#x02212;0.811)</td><td valign="top" align="center" rowspan="1" colspan="1">0.009</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">DES</td><td valign="top" align="center" rowspan="1" colspan="1">10.93 (8.07)</td><td valign="top" align="center" rowspan="1" colspan="1">8.53 (6.67)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.395 (&#x02212;6.493; 1.703)</td><td valign="top" align="center" rowspan="1" colspan="1">0.244</td><td valign="top" align="center" rowspan="1" colspan="1">15.69 (14.05)</td><td valign="top" align="center" rowspan="1" colspan="1">6.72 (7.13)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;8.973 (&#x02212;13.071; &#x02212;4.874)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IES-R-Total</td><td valign="top" align="center" rowspan="1" colspan="1">23.90 (15.35)</td><td valign="top" align="center" rowspan="1" colspan="1">12.30 (11.76)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;11.600 (&#x02212;20.912; &#x02212;2.288)</td><td valign="top" align="center" rowspan="1" colspan="1">0.016</td><td valign="top" align="center" rowspan="1" colspan="1">39.65 (23.12)</td><td valign="top" align="center" rowspan="1" colspan="1">6.05 (5.88)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;33.600 (&#x02212;42.912; &#x02212;24.288)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SCL-90 Total</td><td valign="top" align="center" rowspan="1" colspan="1">62.65 (10.39)</td><td valign="top" align="center" rowspan="1" colspan="1">61.95 (11.55)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.700 (&#x02212;4.985; 3.585)</td><td valign="top" align="center" rowspan="1" colspan="1">0.743</td><td valign="top" align="center" rowspan="1" colspan="1">73.90 (2.94)</td><td valign="top" align="center" rowspan="1" colspan="1">63.25 (12.37)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;10.650 (&#x02212;14.935; &#x02212;6.365)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><p><italic>Data are mean (SD)</italic>.</p><p>TAU, Therapy As Usual group;</p><p><italic>TAU + EMDR, Eye Movement Desensitization and Reprocessing in addition to TAU group</italic>.</p></table-wrap-foot></table-wrap><p>As regards the DES score, there was no significant difference between groups at baseline (Table <xref ref-type="table" rid="T2">2</xref>). Results indicated that the group-by-time effect is explained by the significant difference between dissociative pre- and post-treatment scores for participants who underwent EMDR intervention (Table <xref ref-type="table" rid="T3">3</xref>).</p><p>Moreover, there was also a difference between groups at baseline for the SCL-90-GSI score, with more severe psychiatric symptoms in the TAU + EMDR group (Table <xref ref-type="table" rid="T2">2</xref>). The comparison between pre- and post-treatment indicated a significant improvement in the TAU + EMDR group between T0 and T1, while there was no difference in the TAU group (Table <xref ref-type="table" rid="T3">3</xref>).</p><p>In the case of STAI-1, results indicated that there was a significant difference between the two groups at baseline, as the STAI-1 scores at baseline in TAU + EMDR group were significantly higher than those in TAU group (Table <xref ref-type="table" rid="T2">2</xref>). Concurrently, there was a significant difference between STAI-1 pre- and post-treatment scores in the TAU group but not in the TAU + EMDR group. This indicates that the group-by-time effect was due to the significant difference between groups at baseline and to the significant worsening of state anxiety symptoms in patients in the TAU group (Table <xref ref-type="table" rid="T3">3</xref>).</p><p>With regard to STAI-2, a significant difference between the two groups at baseline was found, as STAI-2 scores at baseline in TAU + EMDR group were significantly higher than those in TAU group (Table <xref ref-type="table" rid="T2">2</xref>). Moreover, there was a significant reduction of STAI-2 scores in the TAU + EMDR group that was not present in the TAU group. This indicates that the improvements over time on trait anxiety were registered only in the TAU+ EMDR treatment group (Table <xref ref-type="table" rid="T3">3</xref>).</p><p>No differences were found before and after treatment in the urine drug testing immunoassays, which showed a similar increase of negative results after the interventions (TAU group from 65% at baseline to 85% at T1; TAU + EMDR group from 70% at baseline to 80% at T1; &#x003c7;<sup>2</sup> = 0.067, <italic>p</italic> = 0.795).</p></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>Overall, all SUD patients included in the study improved their clinical condition with a significant reduction of post-traumatic, dissociative and psychiatric symptoms, regardless of the type of treatment.</p><p>Both TAU and TAU + EMDR interventions had a significant effect in reducing post-traumatic symptoms, but the add-on EMDR proved to have a significant greater effect, allowing a shift from baseline levels above the clinical cut-off to post-treatment normal levels. This finding is in line with those of previous studies (Perez-Dandieu and Tapia, <xref rid="B42" ref-type="bibr">2014</xref>; Brown et al., <xref rid="B8" ref-type="bibr">2015</xref>), which showed that adding EMDR to TAU has a significant effect on post-traumatic symptoms.</p><p>In the same way, according to the results of the present study, the add-on EMDR has an important effect in reducing dissociative symptoms, probably due to the well-recognized effect of EMDR on the reintegration of previous dysfunctionally stored memories (Nardo et al., <xref rid="B37" ref-type="bibr">2013</xref>; van der Hart et al., <xref rid="B53" ref-type="bibr">2013</xref>).</p><p>As regards the effect of EMDR on stress-related psychiatric symptoms, a significant improvement in the global severity of psychiatric symptoms was observed in patients who received add-on EMDR as compared to TAU alone, suggesting that EMDR also has a beneficial impact on a wide range of symptoms of clinical relevance, beyond post-traumatic symptoms.</p><p>In terms of anxiety, our results show a significant effect of add-on EMDR in improving trait anxiety that is not shown in TAU alone. In spite of its tendency to be stable over time, a number of studies revealed that trait anxiety can improve as a result of a psychological intervention over time (V&#x000f8;llestad et al., <xref rid="B55" ref-type="bibr">2011</xref>; Lee et al., <xref rid="B30" ref-type="bibr">2015</xref>). Our results suggest that EMDR intervention might also affect the trait-like tendency to experience anxiety over time and across situations. Another interesting finding of our study is that state anxiety worsened in the TAU alone group, whereas in the TAU + EMDR group it remained stable. An increase of anxiety levels, mediated by adrenocorticotropic hormone, corticosterone, and amygdala corticotrophin releasing factor (CRF), is commonly observed during acute withdrawal stages of substance treatment and recovery programs (Koob and Volkow, <xref rid="B29" ref-type="bibr">2016</xref>). It would seem that the TAU alone does not impact on this increase in anxiety levels, whereas the add-on of an EMDR intervention seems to be able to counterbalance this physiological elevation of anxiety related to abstinence.</p><p>With regard to depressive symptoms, no significant change was observed in either group, although our findings suggest a trend toward improvement in the group that received add-on EMDR, partially confirming previous findings (Hase et al., <xref rid="B25" ref-type="bibr">2008</xref>; Perez-Dandieu and Tapia, <xref rid="B42" ref-type="bibr">2014</xref>).</p><p>This study presents a methodological limitation that may moderate the interpretation of the results outlined so far. The non-randomized design led to the significant differences between the two groups at baseline. In fact, participants who received EMDR treatment showed higher baseline levels of symptoms compared to the group receiving only TAU treatment. These differences at baseline could limit a conclusive interpretation of the results of the study, as the improvements obtained by the group that received EMDR in addition to TAU could also be due to a spontaneous reduction of symptoms linked to the fact that higher reductions are observed when there are higher starting levels.</p><p>At the same time, the findings of the present study suggest that EMDR may be more useful in subjects who experienced more adverse childhood experiences and higher levels of symptoms, in order to strengthen standard treatment that otherwise would only be partially effective, especially on withdrawal-related anxiety. Consistent with previous literature reporting that adverse childhood events have significant implications for substance abuse treatment and that a trauma-informed approach to SUD leads to better treatment outcomes (Felitti et al., <xref rid="B20" ref-type="bibr">1998</xref>; LeTendre and Reed, <xref rid="B31" ref-type="bibr">2017</xref>), our findings suggest that exposure to adverse childhood experiences should be routinely assessed in treatment settings, in order to provide specific interventions to reduce traumatic burden associated with SUD. Future randomized controlled studies with larger samples should better investigate these aspects.</p><p>Another limit of the present study is that aspects related to craving and abstinence were not specifically investigated. The results of our study are in line with previous studies, which show that EMDR has beneficial effects on symptoms related to the traumatic history and only limited effects on additional outcomes (Markus and Hornsveld, <xref rid="B33" ref-type="bibr">2017</xref>). The present study aimed to focus on post-traumatic and associated aspects linked to the relationship between addiction and traumatic burden, but future studies on similar populations should also take into account addict-related aspects.</p><p>This study also has some strengths. The results of the study confirm that EMDR could be a viable and well-accepted add-on treatment for patients with SUD, with some evidence of both efficacy and good compliance. Moreover, to the best of our knowledge this is the first study evaluating the clinical impact of an add-on EMDR intervention focused on both traumatic and addiction-related memories, and it found the first promising evidence of the efficacy of this combined TF- and AF-EMDR protocol. Further studies could evaluate the usefulness of combining TF- and AF-EMDR protocols in different clinical samples.</p><p>Although our results can only be considered preliminary, this study suggests that add-on EMDR is more effective than TAU alone in improving post-traumatic and dissociative symptoms, accompanied also by a reduction in anxiety and overall psychopathology levels.</p><p>The findings of this study underline the importance of assessing ACEs and other traumatic experiences in this population because they may contribute to the onset and maintenance of SUDs and lead to a worsening of psychopathological severity. As a clinical consequence, it could be useful to offer these patients specific add-on treatments addressing both ACEs and traumatic experiences related to addiction, in adjunction to standard treatments.</p><p>Future studies, such as that designed by Markus et al. (<xref rid="B32" ref-type="bibr">2015</xref>) on alcohol-dependent patients, would be better to investigate not only the effectiveness of an EMDR add-on treatment but also the mediators, moderators, and predictors of treatment outcome, in order to be able to delineate effective interventions for these disorders, which represent a major public health problem.</p></sec><sec id="s5"><title>Author contributions</title><p>MB is the national coordinator of the research. MB, IF, and MP were responsible for the conception and the design of the study. MB, TA, AC, PM, CR, and IF were responsible for data collection and for clinical treatments. SC and FO were responsible for the data analysis. IF, MB, LO, and MP contributed to the interpretation of data. SC and FO wrote the article, which was critically revised by all the others authors. All authors have approved the final version of the manuscript.</p><sec><title>Conflict of interest statement</title><p>IF is the president of EMDR Europe Association and the president of EMDR Italy Association. SC, LO, and MP have been invited speakers in national and international EMDR conferences. The other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling Editor declared a shared affiliation, though no other collaboration, with several of the authors, SC, FO, and LO, and states that the process nevertheless met the standards of a fair and objective review.</p></sec></sec></body><back><ack><p>We would like to thank the participants involved in the study for their time and effort. We are also grateful to all the staff of ASST Monza and Comunit&#x000e0; di Capodarco di Fermo for their contribution and unstinting support during the entire study period.</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amaro</surname><given-names>H.</given-names></name><name><surname>Chernoff</surname><given-names>M.</given-names></name><name><surname>Brown</surname><given-names>V.</given-names></name><name><surname>Ar&#x000e9;valo</surname><given-names>S.</given-names></name><name><surname>Gatz</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Does integrated trauma-informed substance abuse treatment increase treatment retention?</article-title>
<source>J. Commun. Psychol.</source>
<volume>35</volume>, <fpage>845</fpage>&#x02013;<lpage>862</lpage>. <pub-id pub-id-type="doi">10.1002/jcop.20185</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>American Psychiatric Association</collab></person-group> (<year>2013</year>). <source>Diagnostic and Statistical Manual of Mental Disorders: Dsm-5</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychiatric Pub Incorporated</publisher-name>.</mixed-citation></ref><ref id="B3"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>A.</given-names></name><name><surname>Steer</surname><given-names>R.</given-names></name></person-group> (<year>1993</year>). <source>Manual for the Beck Depression Inventory</source>. <publisher-loc>San Antonio, TX</publisher-loc>: <publisher-name>Psychological Corporation</publisher-name>.</mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernstein</surname><given-names>E. M.</given-names></name><name><surname>Putnam</surname><given-names>F. W.</given-names></name></person-group> (<year>1986</year>). <article-title>Development, reliability, and validity of a dissociation scale</article-title>. <source>J. Nerv. Ment. Dis</source>. <volume>174</volume>, <fpage>727</fpage>&#x02013;<lpage>735</lpage>. <pub-id pub-id-type="doi">10.1097/00005053-198612000-00004</pub-id><pub-id pub-id-type="pmid">3783140</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisson</surname><given-names>J. I.</given-names></name><name><surname>Roberts</surname><given-names>N. P.</given-names></name><name><surname>Andrew</surname><given-names>M.</given-names></name><name><surname>Cooper</surname><given-names>R.</given-names></name><name><surname>Lewis</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults</article-title>. <source>Cochrane Database Syst. Rev.</source>
<fpage>CD003388</fpage>. <pub-id pub-id-type="doi">10.1002/14651858.CD003388.pub4</pub-id><pub-id pub-id-type="pmid">24338345</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boukezzi</surname><given-names>S.</given-names></name><name><surname>El Khoury-Malhame</surname><given-names>M.</given-names></name><name><surname>Auzias</surname><given-names>G.</given-names></name><name><surname>Reynaud</surname><given-names>E.</given-names></name><name><surname>Rousseau</surname><given-names>P.-F.</given-names></name><name><surname>Richard</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Grey matter density changes of structures involved in Posttraumatic Stress Disorder (PTSD) after recovery following Eye Movement Desensitization and Reprocessing (EMDR) therapy</article-title>. <source>Psychiatry Res.</source>
<volume>266</volume>, <fpage>146</fpage>&#x02013;<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/j.pscychresns.2017.06.009</pub-id><pub-id pub-id-type="pmid">28667881</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>R.</given-names></name><name><surname>Greene</surname><given-names>J.</given-names></name><name><surname>Russ</surname><given-names>E.</given-names></name><name><surname>Dutra</surname><given-names>L.</given-names></name><name><surname>Westen</surname><given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>A multidimensional meta-analysis of psychotherapy for PTSD</article-title>. <source>Am. J. Psychiatry</source>
<volume>162</volume>, <fpage>214</fpage>&#x02013;<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.162.2.214</pub-id><pub-id pub-id-type="pmid">15677582</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>S. H.</given-names></name><name><surname>Gilman</surname><given-names>S. G.</given-names></name><name><surname>Goodman</surname><given-names>E. G.</given-names></name><name><surname>Adler-Tapia</surname><given-names>R.</given-names></name><name><surname>Freng</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Integrated trauma treatment in drug court: combining EMDR therapy and seeking safety</article-title>. <source>J. EMDR Pract. Res</source>. <volume>9</volume>, <fpage>123</fpage>&#x02013;<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1891/1933-3196.9.3.123</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carletto</surname><given-names>S.</given-names></name><name><surname>Borsato</surname><given-names>T.</given-names></name><name><surname>Pagani</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>The role of slow wave sleep in memory pathophysiology: focus on post-traumatic stress disorder and eye movement desensitization and reprocessing</article-title>. <source>Front. Psychol</source>. <volume>8</volume>:<fpage>2050</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyg.2017.02050</pub-id><pub-id pub-id-type="pmid">29213253</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Hu</surname><given-names>M.</given-names></name><name><surname>Liang</surname><given-names>X.</given-names></name></person-group> (<year>2015</year>). <article-title>Eye movement desensitization and reprocessing versus cognitive-behavioral therapy for adult posttraumatic stress disorder: systematic review and meta-analysis</article-title>. <source>J. Nerv. Ment. Dis.</source>
<volume>203</volume>, <fpage>443</fpage>&#x02013;<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1097/NMD.0000000000000306</pub-id><pub-id pub-id-type="pmid">25974059</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.-R.</given-names></name><name><surname>Hung</surname><given-names>K.-W.</given-names></name><name><surname>Tsai</surname><given-names>J.-C.</given-names></name><name><surname>Chu</surname><given-names>H.</given-names></name><name><surname>Chung</surname><given-names>M.-H.</given-names></name><name><surname>Chen</surname><given-names>S.-R.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Efficacy of eye-movement desensitization and reprocessing for patients with posttraumatic-stress disorder: a meta-analysis of randomized controlled trials</article-title>. <source>PLoS ONE</source>
<volume>9</volume>:<fpage>e103676</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0103676</pub-id><pub-id pub-id-type="pmid">25101684</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Creamer</surname><given-names>M.</given-names></name><name><surname>Bell</surname><given-names>R.</given-names></name><name><surname>Failla</surname><given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Psychometric properties of the impact of event scale&#x02014;revised</article-title>. <source>Behav. Res. Ther.</source>
<volume>41</volume>, <fpage>1489</fpage>&#x02013;<lpage>1496</lpage>. <pub-id pub-id-type="doi">10.1016/j.brat.2003.07.010</pub-id><pub-id pub-id-type="pmid">14705607</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>P. R.</given-names></name><name><surname>Parker</surname><given-names>K. C. H.</given-names></name></person-group> (<year>2001</year>). <article-title>Eye movement desensitization and reprocessing (emdr): a meta-analysis</article-title>. <source>J. Consult. Clin. Psychol.</source>
<volume>69</volume>, <fpage>305</fpage>&#x02013;<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1037/0022-006X.69.2.305</pub-id><pub-id pub-id-type="pmid">11393607</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Derogatis</surname><given-names>L. R.</given-names></name></person-group> (<year>1994</year>). <source>SCL-90-R : Symptom Checklist-90-R : Administration, Scoring &#x00026; Procedures Manual</source>. <publisher-loc>Minneapolis, MN</publisher-loc>: <publisher-name>National Computer Systems, Inc</publisher-name>.</mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derogatis</surname><given-names>L. R.</given-names></name><name><surname>Lipman</surname><given-names>R. S.</given-names></name><name><surname>Covi</surname><given-names>L.</given-names></name></person-group> (<year>1973</year>). <article-title>SCL-90: an outpatient psychiatric rating scale&#x02013;preliminary report</article-title>. <source>Psychopharmacol. Bull</source>. <volume>9</volume>, <fpage>13</fpage>&#x02013;<lpage>28</lpage>. <pub-id pub-id-type="pmid">4682398</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragan</surname><given-names>M.</given-names></name><name><surname>Lis-Turlejska</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Prevalence of posttraumatic stress disorder in alcohol dependent patients in Poland</article-title>. <source>Addict. Behav</source>. <volume>32</volume>, <fpage>902</fpage>&#x02013;<lpage>911</lpage>. <pub-id pub-id-type="doi">10.1016/j.addbeh.2006.06.025</pub-id><pub-id pub-id-type="pmid">16857322</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Driessen</surname><given-names>M.</given-names></name><name><surname>Schulte</surname><given-names>S.</given-names></name><name><surname>Luedecke</surname><given-names>C.</given-names></name><name><surname>Schaefer</surname><given-names>I.</given-names></name><name><surname>Sutmann</surname><given-names>F.</given-names></name><name><surname>Ohlmeier</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Trauma and PTSD in patients with alcohol, drug, or dual dependence: a multi-center study</article-title>. <source>Alcohol. Clin. Exp. Res</source>. <volume>32</volume>, <fpage>481</fpage>&#x02013;<lpage>488</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2007.00591.x</pub-id><pub-id pub-id-type="pmid">18215214</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dube</surname><given-names>S. R.</given-names></name><name><surname>Felitti</surname><given-names>V. J.</given-names></name><name><surname>Dong</surname><given-names>M.</given-names></name><name><surname>Chapman</surname><given-names>D. P.</given-names></name><name><surname>Giles</surname><given-names>W. H.</given-names></name><name><surname>Anda</surname><given-names>R. F.</given-names></name></person-group> (<year>2003</year>). <article-title>Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study</article-title>. <source>Pediatrics</source>
<volume>111</volume>, <fpage>564</fpage>&#x02013;<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1542/peds.111.3.564</pub-id><pub-id pub-id-type="pmid">12612237</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubester</surname><given-names>K. A.</given-names></name><name><surname>Braun</surname><given-names>B. G.</given-names></name></person-group> (<year>1995</year>). <article-title>Psychometric properties of the dissociative experiences scale</article-title>. <source>J. Nerv. Ment. Dis.</source>
<volume>183</volume>, <fpage>231</fpage>&#x02013;<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1097/00005053-199504000-00008</pub-id><pub-id pub-id-type="pmid">7714511</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felitti</surname><given-names>V. J.</given-names></name><name><surname>Anda</surname><given-names>R. F.</given-names></name><name><surname>Nordenberg</surname><given-names>D.</given-names></name><name><surname>Williamson</surname><given-names>D. F.</given-names></name><name><surname>Spitz</surname><given-names>A. M.</given-names></name><name><surname>Edwards</surname><given-names>V.</given-names></name><etal/></person-group>. (<year>1998</year>). <article-title>Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults</article-title>. <source>Am. J. Prev. Med.</source>
<volume>14</volume>, <fpage>245</fpage>&#x02013;<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1016/S0749-3797(98)00017-8</pub-id><pub-id pub-id-type="pmid">9635069</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frischholz</surname><given-names>E. J.</given-names></name><name><surname>Braun</surname><given-names>B. G.</given-names></name><name><surname>Sachs</surname><given-names>R. G.</given-names></name><name><surname>Hopkins</surname><given-names>L.</given-names></name><name><surname>Schaeffer</surname><given-names>D. M.</given-names></name><name><surname>Lewis</surname><given-names>J.</given-names></name><etal/></person-group> (<year>1990</year>). <article-title>The dissociative experiences scale: further replication and validation</article-title>. <source>Dissoc. Prog. Dissoc. Disord.</source>
<volume>3</volume>, <fpage>151</fpage>&#x02013;<lpage>153</lpage>.</mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>B. F.</given-names></name><name><surname>Saha</surname><given-names>T. D.</given-names></name><name><surname>Ruan</surname><given-names>W. J.</given-names></name><name><surname>Goldstein</surname><given-names>R. B.</given-names></name><name><surname>Chou</surname><given-names>S. P.</given-names></name><name><surname>Jung</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Epidemiology of DSM-5 drug use disorder</article-title>. <source>JAMA Psychiatry</source>
<volume>73</volume>, <fpage>39</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2015.2132</pub-id><pub-id pub-id-type="pmid">26580136</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>J. G.</given-names></name><name><surname>McLaughlin</surname><given-names>K. A.</given-names></name><name><surname>Berglund</surname><given-names>P. A.</given-names></name><name><surname>Gruber</surname><given-names>M. J.</given-names></name><name><surname>Sampson</surname><given-names>N. A.</given-names></name><name><surname>Zaslavsky</surname><given-names>A. M.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: associations with first onset of DSM-IV disorders</article-title>. <source>Arch. Gen. Psychiatry</source>
<volume>67</volume>, <fpage>113</fpage>&#x02013;<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2009.186</pub-id><pub-id pub-id-type="pmid">20124111</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hase</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>CravEx: an EMDR approach to treat substance abuse and addiction</article-title>, in <source>Eye Movement Desensitization and Reprocessing (EMDR) Scripted Protocols: Special Populations</source>, eds <person-group person-group-type="editor"><name><surname>Luber</surname><given-names>M.</given-names></name><name><surname>Luber</surname><given-names>M.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer Publishing Co</publisher-name>), <fpage>467</fpage>&#x02013;<lpage>488</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://search.ebscohost.com/login.aspx?direct=true&#x00026;db=psyh&#x00026;AN=2009-16776-037&#x00026;site=ehost-live">http://search.ebscohost.com/login.aspx?direct=true&#x00026;db=psyh&#x00026;AN=2009-16776-037&#x00026;site=ehost-live</ext-link></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hase</surname><given-names>M.</given-names></name><name><surname>Schallmayer</surname><given-names>S.</given-names></name><name><surname>Sack</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>EMDR reprocessing of the addiction memory: pretreatment, posttreatment, and 1-month follow-up</article-title>. <source>J. EMDR Pract. Res</source>. <volume>2</volume>, <fpage>170</fpage>&#x02013;<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1891/1933-3196.2.3.170</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffries</surname><given-names>F. W.</given-names></name><name><surname>Davis</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>What is the role of eye movements in eye movement desensitization and reprocessing (EMDR) for post-traumatic stress disorder (PTSD)? a review</article-title>. <source>Behav. Cogn. Psychother</source>. <volume>41</volume>, <fpage>290</fpage>&#x02013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1017/S1352465812000793</pub-id><pub-id pub-id-type="pmid">23102050</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Knipe</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Dysfunctional positive affects: to assist clients with unwanted avoidance defenses</article-title>, in <source>Eye Movement Desensitization and Reprocessing (EMDR) Scripted Protocols: Special Populations</source>, eds <person-group person-group-type="editor"><name><surname>Luber</surname><given-names>M.</given-names></name><name><surname>Luber</surname><given-names>M.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer Publishing Co.</publisher-name>), <fpage>451</fpage>&#x02013;<lpage>452</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://search.ebscohost.com/login.aspx?direct=true&#x00026;db=psyh&#x00026;AN=2009-16776-033&#x00026;site=ehost-live">http://search.ebscohost.com/login.aspx?direct=true&#x00026;db=psyh&#x00026;AN=2009-16776-033&#x00026;site=ehost-live</ext-link></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koob</surname><given-names>G. F.</given-names></name></person-group> (<year>2013</year>). <article-title>Addiction is a reward deficit and stress surfeit disorder</article-title>. <source>Front. Psychiatry</source>
<volume>4</volume>:<fpage>72</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyt.2013.00072</pub-id><pub-id pub-id-type="pmid">23914176</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koob</surname><given-names>G. F.</given-names></name><name><surname>Volkow</surname><given-names>N. D.</given-names></name></person-group> (<year>2016</year>). <article-title>Neurobiology of addiction: a neurocircuitry analysis</article-title>. <source>Lancet Psychiatry</source>
<volume>3</volume>, <fpage>760</fpage>&#x02013;<lpage>773</lpage>. <pub-id pub-id-type="doi">10.1016/S2215-0366(16)00104-8</pub-id><pub-id pub-id-type="pmid">27475769</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>J. K.</given-names></name><name><surname>Wachholtz</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>The benefit of heart rate variability biofeedback and relaxation training in reducing trait anxiety</article-title>. <source>Hanguk Simni Hakhoe Chi Kongang Korean.</source>
<volume>20</volume>, <fpage>391</fpage>&#x02013;<lpage>408</lpage>. <pub-id pub-id-type="pmid">27099546</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeTendre</surname><given-names>M. L.</given-names></name><name><surname>Reed</surname><given-names>M. B.</given-names></name></person-group> (<year>2017</year>). <article-title>The effect of adverse childhood experience on clinical diagnosis of a substance use disorder: results of a nationally representative study</article-title>. <source>Subst. Use Misuse</source>
<volume>52</volume>, <fpage>689</fpage>&#x02013;<lpage>697</lpage>. <pub-id pub-id-type="doi">10.1080/10826084.2016.1253746</pub-id><pub-id pub-id-type="pmid">28145794</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markus</surname><given-names>W.</given-names></name><name><surname>de Weert-van Oene</surname><given-names>G. H.</given-names></name><name><surname>Becker</surname><given-names>E. S.</given-names></name><name><surname>DeJong</surname><given-names>C. A. J.</given-names></name></person-group> (<year>2015</year>). <article-title>A multi-site randomized study to compare the effects of Eye Movement Desensitization and Reprocessing (EMDR) added to TAU versus TAU to reduce craving and drinking behavior in alcohol dependent outpatients: study protocol</article-title>. <source>BMC Psychiatry</source>
<volume>15</volume>:<fpage>15</fpage>. <pub-id pub-id-type="doi">10.1186/s12888-015-0431-z</pub-id><pub-id pub-id-type="pmid">25652365</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markus</surname><given-names>W.</given-names></name><name><surname>Hornsveld</surname><given-names>H. K.</given-names></name></person-group> (<year>2017</year>). <article-title>EMDR Interventions in Addiction</article-title>. <source>J. EMDR Pract. Res</source>. <volume>11</volume>, <fpage>3</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1891/1933-3196.11.1.3</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>The feeling-state theory of impulse-control disorders and the impulse-control disorder protocol</article-title>. <source>Traumatology</source>
<volume>16</volume>, <fpage>2</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1177/1534765610365912</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>K. L.</given-names></name><name><surname>Lynskey</surname><given-names>M.</given-names></name><name><surname>Teesson</surname><given-names>M.</given-names></name><name><surname>Ross</surname><given-names>J.</given-names></name><name><surname>Darke</surname><given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates</article-title>. <source>Drug Alcohol Depend.</source>
<volume>77</volume>, <fpage>243</fpage>&#x02013;<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2004.08.016</pub-id><pub-id pub-id-type="pmid">15734224</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>A.</given-names></name><name><surname>Steele</surname><given-names>M.</given-names></name><name><surname>Dube</surname><given-names>S. R.</given-names></name><name><surname>Bate</surname><given-names>J.</given-names></name><name><surname>Bonuck</surname><given-names>K.</given-names></name><name><surname>Meissner</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Adverse Childhood Experiences (ACEs) questionnaire and Adult Attachment Interview (AAI): implications for parent child relationships</article-title>. <source>Child Abuse Negl</source>. <volume>38</volume>, <fpage>224</fpage>&#x02013;<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1016/j.chiabu.2013.09.004</pub-id><pub-id pub-id-type="pmid">24670331</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nardo</surname><given-names>D.</given-names></name><name><surname>H&#x000f6;gberg</surname><given-names>G.</given-names></name><name><surname>Lanius</surname><given-names>R. A.</given-names></name><name><surname>Jacobsson</surname><given-names>H.</given-names></name><name><surname>Jonsson</surname><given-names>C.</given-names></name><name><surname>H&#x000e4;llstr&#x000f6;m</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Gray matter volume alterations related to trait dissociation in PTSD and traumatized controls</article-title>. <source>Acta Psychiatr. Scand.</source>
<volume>128</volume>, <fpage>222</fpage>&#x02013;<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1111/acps.12026</pub-id><pub-id pub-id-type="pmid">23113800</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>National Collaborating Centre for Mental Health (UK)</collab></person-group> (<year>2005</year>). <source>Post-Traumatic Stress Disorder: The Management of PTSD in Adults and Children in Primary and Secondary Care.</source>
<publisher-loc>Leicester</publisher-loc>: <publisher-name>Gaskell</publisher-name> Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK56494/">http://www.ncbi.nlm.nih.gov/books/NBK56494/</ext-link> (Accessed June 24, 2015).</mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagani</surname><given-names>M.</given-names></name><name><surname>Amann</surname><given-names>B. L.</given-names></name><name><surname>Landin-Romero</surname><given-names>R.</given-names></name><name><surname>Carletto</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Eye movement desensitization and reprocessing and slow wave sleep: a putative mechanism of action</article-title>. <source>Front. Psychol</source>. <volume>8</volume>:<fpage>1935</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyg.2017.01935</pub-id><pub-id pub-id-type="pmid">29163309</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagani</surname><given-names>M.</given-names></name><name><surname>Di Lorenzo</surname><given-names>G.</given-names></name><name><surname>Monaco</surname><given-names>L.</given-names></name><name><surname>Daverio</surname><given-names>A.</given-names></name><name><surname>Giannoudas</surname><given-names>I.</given-names></name><name><surname>La Porta</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Neurobiological response to EMDR therapy in clients with different psychological traumas</article-title>. <source>Front. Psychol.</source>
<volume>6</volume>:<fpage>1614</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyg.2015.01614</pub-id><pub-id pub-id-type="pmid">26579006</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagani</surname><given-names>M.</given-names></name><name><surname>Di Lorenzo</surname><given-names>G.</given-names></name><name><surname>Verardo</surname><given-names>A. R.</given-names></name><name><surname>Nicolais</surname><given-names>G.</given-names></name><name><surname>Monaco</surname><given-names>L.</given-names></name><name><surname>Lauretti</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Neurobiological correlates of EMDR monitoring - an EEG study</article-title>. <source>PLoS ONE</source>
<volume>7</volume>:<fpage>e45753</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0045753</pub-id><pub-id pub-id-type="pmid">23049852</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Dandieu</surname><given-names>B.</given-names></name><name><surname>Tapia</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Treating trauma in addiction with EMDR: a pilot study</article-title>. <source>J. Psychoactive Drugs</source>
<volume>46</volume>, <fpage>303</fpage>&#x02013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1080/02791072.2014.921744</pub-id><pub-id pub-id-type="pmid">25188700</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Popky</surname><given-names>A. J.</given-names></name></person-group> (<year>2005</year>). <article-title>DeTUR, an urge reduction protocol for addictions and dysfunctional behaviors</article-title>, in <source>EMDR Solutions: Pathways to Healing</source>, ed <person-group person-group-type="editor"><name><surname>Shapiro</surname><given-names>R.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Norton</publisher-name>), <fpage>167</fpage>&#x02013;<lpage>188</lpage>.</mixed-citation></ref><ref id="B44"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Popky</surname><given-names>A. J.</given-names></name></person-group> (<year>2010</year>). <article-title>The desensitization of triggers and urge reprocessing (DeTUR) protocol</article-title>, in <source>Eye Movement Desensitization and Reprocessing (EMDR) Scripted Protocols: Special Populations</source>, eds <person-group person-group-type="editor"><name><surname>Luber</surname><given-names>M.</given-names></name><name><surname>Luber</surname><given-names>M.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer Publishing Co.</publisher-name>), <fpage>489</fpage>&#x02013;<lpage>511</lpage>.</mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prinz</surname><given-names>U.</given-names></name><name><surname>Nutzinger</surname><given-names>D. O.</given-names></name><name><surname>Schulz</surname><given-names>H.</given-names></name><name><surname>Petermann</surname><given-names>F.</given-names></name><name><surname>Braukhaus</surname><given-names>C.</given-names></name><name><surname>Andreas</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Comparative psychometric analyses of the SCL-90-R and its short versions in patients with affective disorders</article-title>. <source>BMC Psychiatry</source>
<volume>13</volume>:<fpage>104</fpage>. <pub-id pub-id-type="doi">10.1186/1471-244X-13-104</pub-id><pub-id pub-id-type="pmid">23537095</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>M.</given-names></name><name><surname>Hinchliffe</surname><given-names>K.</given-names></name><name><surname>Asamoah</surname><given-names>V.</given-names></name><name><surname>Kouimtsidis</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Trauma and post-traumatic stress disorder in a drug treatment community service</article-title>. <source>Psychiatrist</source>
<volume>35</volume>, <fpage>256</fpage>&#x02013;<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1192/pb.bp.110.030379</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>M.</given-names></name><name><surname>Mezey</surname><given-names>G.</given-names></name><name><surname>Chapman</surname><given-names>M.</given-names></name><name><surname>Wheeler</surname><given-names>M.</given-names></name><name><surname>Drummond</surname><given-names>C.</given-names></name><name><surname>Baldacchino</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Co-morbid post-traumatic stress disorder in a substance misusing clinical population</article-title>. <source>Drug Alcohol Depend</source>. <volume>77</volume>, <fpage>251</fpage>&#x02013;<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2004.08.017</pub-id><pub-id pub-id-type="pmid">15734225</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>N. P.</given-names></name><name><surname>Roberts</surname><given-names>P. A.</given-names></name><name><surname>Jones</surname><given-names>N.</given-names></name><name><surname>Bisson</surname><given-names>J. I.</given-names></name></person-group> (<year>2015</year>). <article-title>Psychological interventions for post-traumatic stress disorder and comorbid substance use disorder: a systematic review and meta-analysis</article-title>. <source>Clin. Psychol. Rev</source>. <volume>38</volume>, <fpage>25</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.cpr.2015.02.007</pub-id><pub-id pub-id-type="pmid">25792193</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>F.</given-names></name></person-group> (<year>2001</year>). <source>Eye Movement Desensitization and Reprocessing (EMDR): Basic Principles, Protocols, and Procedures, 2nd Edn</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Guilford Press</publisher-name>.</mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>F.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of eye movement desensitization and reprocessing (EMDR) therapy in medicine: addressing the psychological and physical symptoms stemming from adverse life experiences</article-title>. <source>Perm. J</source>. <volume>18</volume>, <fpage>71</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.7812/TPP/13-098</pub-id><pub-id pub-id-type="pmid">24626074</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Spielberger</surname><given-names>C. D.</given-names></name><name><surname>Gorsuch</surname><given-names>R. L.</given-names></name><name><surname>Lushene</surname><given-names>R.</given-names></name><name><surname>Vagg</surname><given-names>P. R.</given-names></name><name><surname>Jacobs</surname><given-names>G. A.</given-names></name></person-group> (<year>1983</year>). <source>Manual for the State-Trait Anxiety Inventory</source>. <publisher-loc>Palo Alto, CA</publisher-loc>: <publisher-name>Consulting Psychologists Press</publisher-name>.</mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valiente-G&#x000f3;mez</surname><given-names>A.</given-names></name><name><surname>Moreno-Alc&#x000e1;zar</surname><given-names>A.</given-names></name><name><surname>Treen</surname><given-names>D.</given-names></name><name><surname>Cedr&#x000f3;n</surname><given-names>C.</given-names></name><name><surname>Colom</surname><given-names>F.</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>V.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>EMDR beyond PTSD: A Systematic Literature Review</article-title>. <source>Front. Psychol</source>. <volume>8</volume>:<fpage>1668</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyg.2017.01668</pub-id><pub-id pub-id-type="pmid">29018388</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Hart</surname><given-names>O.</given-names></name><name><surname>Groenendijk</surname><given-names>M.</given-names></name><name><surname>Gonzalez</surname><given-names>A.</given-names></name><name><surname>Mosquera</surname><given-names>D.</given-names></name><name><surname>Solomon</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Dissociation of the personality and EMDR therapy in complex trauma-related disorders: applications in the stabilization phase</article-title>. <source>J. EMDR Pract. Res</source>. <volume>7</volume>, <fpage>81</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1891/1933-3196.7.2.81</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Etten</surname><given-names>M. L.</given-names></name><name><surname>Taylor</surname><given-names>S.</given-names></name></person-group> (<year>1998</year>). <article-title>Comparative efficacy of treatments for post-traumatic stress disorder: a meta-analysis</article-title>. <source>Clin. Psychol. Psychother.</source>
<volume>5</volume>, <fpage>126</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1099-0879(199809)5:3&#x0003c;126::AID-CPP153&#x0003e;3.0.CO;2-H</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x000f8;llestad</surname><given-names>J.</given-names></name><name><surname>Sivertsen</surname><given-names>B.</given-names></name><name><surname>Nielsen</surname><given-names>G. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Mindfulness-based stress reduction for patients with anxiety disorders: evaluation in a randomized controlled trial</article-title>. <source>Behav. Res. Ther.</source>
<volume>49</volume>, <fpage>281</fpage>&#x02013;<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1016/j.brat.2011.01.007</pub-id><pub-id pub-id-type="pmid">21320700</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y. P.</given-names></name><name><surname>Gorenstein</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Psychometric properties of the beck depression inventory-II: a comprehensive review</article-title>. <source>Rev. Bras. Psiquiatr</source>. <volume>35</volume>, <fpage>416</fpage>&#x02013;<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1590/1516-4446-2012-1048</pub-id><pub-id pub-id-type="pmid">24402217</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>D. S.</given-names></name><name><surname>Marmar</surname><given-names>C. R.</given-names></name></person-group> (<year>1997</year>). <article-title>The impact of event scale-revised</article-title>, in <source>Assessing psychological Trauma and PTSD</source>, eds <person-group person-group-type="editor"><name><surname>Wilson</surname><given-names>J. P.</given-names></name><name><surname>Keane</surname><given-names>T. M.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Guilford Press</publisher-name>), <fpage>399</fpage>&#x02013;<lpage>411</lpage>. </mixed-citation></ref><ref id="B58"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization (WHO)</collab></person-group> (<year>2013</year>). <source>Guidelines for the Management of Conditions Specifically Related to Stress</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO</publisher-name>.</mixed-citation></ref></ref-list></back></article>